Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma

@article{Woelfl2004ExpressionOM,
  title={Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma},
  author={Matthias Woelfl and Achim A. Jungbluth and Federico Garrido and Teresa Cabrera and Sharon Meyen-Southard and Ruediger Spitz and Karen Ernestus and Frank Berthold},
  journal={Cancer Immunology, Immunotherapy},
  year={2004},
  volume={54},
  pages={400-406}
}
Background: Neuroblastoma is the most common solid extracranial tumor in childhood, still with poor survival rates for metastatic disease. Neuroblastoma cells are of neuroectodermal origin and express a number of cancer germline (CG) antigens. These CG antigens may represent a potential target for immunotherapy such as peptide-based vaccination strategies. Objective: The purpose of this study was to analyze the presence of MAGE-A1, MAGE-A3/A6, and NY-ESO-1 on an mRNA and protein level and to… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 29 extracted citations

The Cell Biology of Neuroblastoma

View 3 Excerpts
Highly Influenced

Expansion of cancer germline antigen-specific cytotoxic T lymphocytes for immunotherapy.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine • 2017

PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2017
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 42 references

Immunologic mechanisms of antitumor activity.

Seminars in oncology • 2002
View 1 Excerpt

Similar Papers

Loading similar papers…